We used the adrenocortical carcinoma SW-13 cell model in which BRG1 and BRM are not expressed because of epigenetic silencing to examine HSA domain function (Davis et al, 2016). This evidence concerns the gene SMARCA2 and adrenal cortex carcinoma.